2015 Award and Scholarship Applications Open Nominate a deserving colleague or apply today! Application deadline October 31, 2014

The Society for Public Health Education (SOPHE) recognizes outstanding contributions to health education and health promotion through its yearly awards program. Award recipients will be recognized at the SOPHE Annual Meeting Awards Ceremony and Gala in Portland, Oregon.

Click here to view award information and applications

Professional Awards
DISTINGUISHED FELLOW AWARD

SOPHE’s highest form of recognition for a SOPHE member; recognizes individuals who have made significant and lasting contributions to SOPHE and the profession of health education.


HEALTH EDUCATION MENTOR AWARD

Recognizes individuals who have provided excellence in mentorship to health educators in their preparation, performance, and practice, and who have served to successfully bridge the rift between practice and research.

 

OPEN SOCIETY AWARD
Recognizes an individual or group who embodies and promotes an Open Society, through research, practice, and/or teaching.

 

HORIZON AWARD
Recognizes individuals who have been health educators in any setting for less than five years and who are believed to have potential to achieve prominence in the health education profession.

TECHNOLOGY AWARD
Recognizes individuals or groups who use or develop technology to impact the practice of health education in schools, worksites, universities, the community, or health care.

 

OPEN SOCIETY AWARD
Recognizes an individual or group who embodies and promotes an Open Society, through research, practice, and/or teaching.

 

SOPHE CHAPTER AWARD FOR EXCELLENCE
Recognizes and publicizes creative, effective and replicable methods implemented by SOPHE chapters to deliver one or more core member services.

 

New Scholars Program for 74th Annual Scientific Sessions

The American Diabetes Association and Eli Lilly and Company are pleased to announce the creation of the American Diabetes Association Scholars Program.  The program, made possible through $1.1 million in support from Lilly, will provide scholarships for up to 100 scholars from outside the U.S. to attend this year’s Scientific Sessions, the world’s largest scientific and medical conference focused on diabetes and its complications. 

“The American Diabetes Association is thrilled to join with Eli Lilly and Company to award the American Diabetes Association Scholars Program,” said Robert E. Ratner, MD, FACP, FACE, chief scientific & medical officer, American Diabetes Association. “Lilly’s support provides scientists from countries around the world that are seeing a significant increase in diabetes, the opportunity to attend this educational program and be trained in the clinical management of the disease. Then, they will be able to return to their home country and conduct these educational programs, furthering our fight to Stop Diabetes® across the globe.”

The Association’s 74th Annual Scientific Sessions, to be held in San Francisco June 13-17, brings together physicians, scientists and other health care professionals from around the world to learn about the latest advances in basic and clinical science for diabetes. Selected scholars will attend the program, as well as participate in a professional education program which will provide training and resources for scholars to serve as faculty for professional education programs when they return to their home countries.  The Association will provide reporting tools for scholars and track the presentation opportunities they undertake.

“Diabetes is a global epidemic, so it’s critical that clinicians and scientists across the world have access to the most recent information in order to appropriately treat and fight this disease,” said Robert Heine, vice president, medical affairs, Lilly Diabetes. “Lilly is pleased to provide support for the Association’s scholars program and looks forward to this year’s Scientific Sessions.”

– See more at: http://www.diabetes.org/newsroom/press-releases/2014/scholars-awards.html#sthash.kkAJG3Zj.dpuf

Youth Tennis Scholarships Available

WTT accepting applications through April 16

NEW YORK, N.Y. (January 18, 2012) – World TeamTennis is currently
accepting applications from youth tennis players with diabetes for the
Novo Nordisk Donnelly Awards.  The Novo Nordisk Donnelly Awards annually
distribute $25,000 in scholarships, including two one-time $5,000 national
scholarships and six one-time $2,500 regional scholarships.

The scholarships are awarded to male and female athletes ages 12-21, who
have diabetes and play tennis competitively in tournaments or on their
school team.  Applications must be received by April 16, 2012, along with
two letters of recommendation and a short essay explaining the
significance of diabetes in the applicant’s life.  The awards are to be
used for education, tennis development and/or medical care.

The recipients of the $5,000 national scholarships will receive their
awards at a World TeamTennis Pro League match this summer from WTT
co-founder Billie Jean King.  The scholarship program was established by
King, through WTT Charities, in 1998 to encourage children with diabetes
to lead an active life and compete in tennis.

The Novo Nordisk Donnelly Awards are named after two long-time World
TeamTennis executives and tennis champions, Diane Donnelly Stone and
Tracey Donnelly Maltby, who are sisters.  Stone was an All-American and
NCAA doubles champion at Northwestern University, and Maltby earned
All-Big Ten honors at the University of Iowa.  Both women have lived
successfully with diabetes since childhood.

Novo Nordisk, a world leader in diabetes care, has been the title sponsor
of the award since 2002.  For more details on the Novo Nordisk Donnelly
Awards and to download an application form, visit www.WTT.com/DonnellyAwards.  For more information, contact Diane Donnelly Stone at dstone@wtt.com or 212-586-3444 ext. 20.

About Novo Nordisk:

Headquartered in Denmark, Novo Nordisk is a global healthcare company with more than 88 years of innovation and leadership in diabetes care.  The company also has leading positions within hemophilia care, growth hormone therapy and hormone replacement therapy.  For more information, visit novonordisk-us.com.

Kathy Latimer
Diabetes Education and Camping Association